Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study
Bertrand Baussart(Centre National de la Recherche Scientifique), S. Gaillard(Hôpital Foch), Guillaume Assié(Centre National de la Recherche Scientifique), Anne Jouinot, L. Foubert(Hôpital Foch), Chiara Villa(Centre National de la Recherche Scientifique), Anthony Dohan(Université Paris Cité), Laure Cazabat(Hôpital Foch), Marie‐Laure Raffin‐Sanson(Hôpital Cochin), Jérôme Bertherat(Centre National de la Recherche Scientifique), Michèle Bernier(Hôpital Foch), Fidéline Bonnet-Serrano(Centre National de la Recherche Scientifique)
Cited by 49
Related Papers
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665
SDHA is a tumor suppressor gene causing paraganglioma
|Human Molecular Genetics|2010|651
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434